Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Combined use of a novel cardioplegic formula with MPS® (Myocardial protection system) versus Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| cardioplegia with MPS® (Myocardial protection system) | cardioplegic formula with MPS® (Myocardial protection system); use of a cardioplegic formula in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation |
| |
| cardioplegia with Cardioplexol ® | cardioplegic formula with Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| use of a cardioplegic formula in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation | Procedure | use of a novel cardioplegic formula with MPS® (Myocardial protection system) versus Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system). |
| Measure | Description | Time Frame |
|---|---|---|
| Change in lab values for cardial biomarkers | cardial biomarkers measured are high sensitive troponin T (hs-TrT), Creatinkinase, (CK) Creatinkinase myocardial type (CK-MB) | perioperative during hospital stay for CABG |
| Measure | Description | Time Frame |
|---|---|---|
| mortality | death after coronary artery bypass grafting | 30 days after CABG |
| need for intensive care unit | duration of stay at intensive care unit |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients undergoing isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system) at the department of cardial surgery University Hospital Basel Switzerland
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Oliver Reuthebuch, PD MD | University Hospital Basel, CH-4031 Basel | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Klinik für Herzchirurgie, Universitätsspital Basel | Basel | 4031 | Switzerland |
Not provided
Not provided
Not provided
Not provided
|
| perioperative during hospital stay for CABG |
| dysrhythmia | rhythm disturbance after coronary artery bypass grafting | perioperative during hospital stay for CABG |
| bleeding | bleeding complication after coronary artery bypass grafting | perioperative during hospital stay for CABG |
| ID | Term |
|---|---|
| D001026 | Coronary Artery Bypass |
| ID | Term |
|---|---|
| D009204 | Myocardial Revascularization |
| D006348 | Cardiac Surgical Procedures |
| D013504 | Cardiovascular Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D058017 | Vascular Grafting |
| D014656 | Vascular Surgical Procedures |
| D019616 | Thoracic Surgical Procedures |
Not provided
Not provided